These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2995829)

  • 1. Amplification and altered expression of the c-myc oncogene in A-MuLV-transformed fibroblasts.
    Nepveu A; Fahrlander PD; Yang JQ; Marcu KB
    Nature; 1985 Oct 3-9; 317(6036):440-3. PubMed ID: 2995829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
    Colledge WH; Gebhardt A; Edge MD; Bell JC
    Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus.
    Mushinski JF; Bauer SR; Potter M; Reddy EP
    Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1073-7. PubMed ID: 6302668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
    Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
    Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.
    Goff SP; Tabin CJ; Wang JY; Weinberg R; Baltimore D
    J Virol; 1982 Jan; 41(1):271-85. PubMed ID: 6283119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
    Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
    Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA.
    Srinivasan A; Reddy EP; Aaronson SA
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2077-81. PubMed ID: 6264461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas.
    Mushinski JF; Potter M; Bauer SR; Reddy EP
    Science; 1983 May; 220(4599):795-8. PubMed ID: 6687762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sister chromatid exchanges and chromosomal aberrations in mouse cells infected with the Abelson and Moloney leukemia viruses.
    Majone F; Montaldi A; Saggioro D; Bianchi LC; Levis AG
    Carcinogenesis; 1988 Jul; 9(7):1229-31. PubMed ID: 3133128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.
    Witte ON; Goff S; Rosenberg N; Baltimore D
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4993-7. PubMed ID: 6254050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of flat revertant cell lines from A-MuLV-transformed fibroblasts.
    Glass DJ; Rees-Jones RW; Goff SP
    Oncogene Res; 1990; 5(3):175-85. PubMed ID: 2157187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNase I sensitivity of immunoglobulin light chain genes in Abelson murine leukemia virus transformed pre-B cell lines.
    Persiani DM; Selsing E
    Nucleic Acids Res; 1989 Jul; 17(13):5339-48. PubMed ID: 2548157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
    Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abelson murine leukemia virus induces platelet-derived growth factor-independent fibroblast growth: correlation with kinase activity and dissociation from full morphologic transformation.
    Rees-Jones RW; Goldfarb M; Goff SP
    Mol Cell Biol; 1989 Jan; 9(1):278-87. PubMed ID: 2538721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption and activation of the c-myb locus by M-MULV insertion in plasmacytoid lymphosarcomas induced by pristane and Abelson viruses.
    Shen-Ong GL; Reddy EP; Potter M; Mushinski JF
    Curr Top Microbiol Immunol; 1984; 113():41-6. PubMed ID: 6090070
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.
    Ohno S; Migita S; Wiener F; Babonits M; Klein G; Mushinski JF; Potter M
    J Exp Med; 1984 Jun; 159(6):1762-77. PubMed ID: 6202819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.